![Shawn Rose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: - $ as of 30/05/2026
Shawn Rose currently works at Nkarta, Inc., as Chief Medical Officer, Head-Research & Development from 2025.
Dr. Rose also formerly worked at Vividion Therapeutics, Inc., as Chief Development Officer-Immunology and Magenta Therapeutics, Inc., as Senior Vice President & Head-Clinical Development.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NKARTA, INC. -.--% | 16/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| NKARTA, INC. | Chief Tech/Sci/R&D Officer | 22/06/2025 |
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 06/02/2023 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
